Latest news
Medtronic’s all-in-one mapping and ablation system gains expanded CE mark approval - Cardiovascular BusinessCardiovascular Business · Fri, 07 Aug 2026 20:30:01 GMTMedtronic gets CE mark for ablation to treat ventricular tachycardia - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 15:33:45 GMTCoronary Drug-Coated Balloon Catheter Market (2026 - 2033) - Grand View ResearchGrand View Research · Fri, 07 Aug 2026 05:57:12 GMTLaparoscopic Management of Sigmoid Colon Perforation With Transanal Extrusion of a Ventriculoperitoneal Shunt Nine Weeks After Placement: A Case Report - CureusCureus · Fri, 07 Aug 2026 00:01:24 GMTMedtronic announces expanded CE-mark indication of Affera system for ventricular arrhythmia treatment - Cardiac Rhythm NewsCardiac Rhythm News · Thu, 06 Aug 2026 16:14:16 GMTMedtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias - MedtronicMedtronic · Thu, 06 Aug 2026 12:55:10 GMTMedtronic wins expanded indication in Europe for Affera to treat VT - MassDeviceMassDevice · Thu, 06 Aug 2026 12:37:39 GMTSphere-9 Maps and Ablates Ventricular Arrhythmias With Two Energies - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMT